Based on our data and known mechanisms, these observations suggest that tumor core colocalization of PD-L1 positive tumor cells and PD-L1/CD8 dual positive lymphocytes may represent the optimal scenario for maximal tumor cell killing when treating with PD-1/PD-L1 inhibitors. This evidence concerns the gene CD274 and neoplasm.